Acdal, Flordelyn M.

HRN: 14-77-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
AMPICILLIN 500MG (VIAL)
04/12/2022
04/19/2022
IV
2G
Q6
PROM X 14H
Waiting Final Action 
04/13/2022
CEFUROXIME 500MG (TAB)
04/13/2022
04/20/2022
PO
500
Q12
PROM X 29
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: